Clinical Trial Detail

NCT ID NCT01876641
Title Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Iowa
Indications

melanoma

Therapies

Decitabine + Vemurafenib

Age Groups: adult senior

Additional content available in CKB BOOST